Literature DB >> 6352884

Roles of site and timing of the morning insulin injection in type 1 diabetes.

M F Witt, N H White, J V Santiago.   

Abstract

To investigate the effect of site and timing of insulin injection on post-breakfast plasma glucose concentration, 23 children with type 1 diabetes were given their usual mixture of short- and intermediate-acting insulin five minutes prior to breakfast on one day and between 15 and 60 minutes before breakfast on the alternate day, depending on their 7:00 AM fasting blood glucose concentration. Thirteen children received insulin in an extremity, and 10 in the abdominal wall. Plasma insulin and glucose patterns were similar for the two injection sites. The mean post-breakfast peak glucose increment was significantly lower and the mean increment in free insulin values during the first hour after breakfast was higher on the day when insulin preceded breakfast by 30 to 60 minutes. Thus, significant reductions in post-breakfast hyperglycemia can be achieved by increasing the interval between the injection and breakfast in proportion to the fasting capillary glucose concentration. The timing of the morning insulin injection may be more important than the injection site.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352884     DOI: 10.1016/s0022-3476(83)80577-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Interval between insulin injection and breakfast in diabetes.

Authors:  A H Sackey; I G Jefferson
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

Review 2.  Management of insulin-dependent diabetes mellitus.

Authors:  D M Nathan
Journal:  Drugs       Date:  1992       Impact factor: 9.546

3.  The clinical applications of a systems approach.

Authors:  Andrew C Ahn; Muneesh Tewari; Chi-Sang Poon; Russell S Phillips
Journal:  PLoS Med       Date:  2006-05-23       Impact factor: 11.069

4.  Randomized crossover study to examine the necessity of an injection-to-meal interval in patients with type 2 diabetes and human insulin.

Authors:  Nicolle Müller; Thomas Frank; Christof Kloos; Thomas Lehmann; Gunter Wolf; Ulrich Alfons Müller
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.